Published in Arch Dermatol on February 01, 1997
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol (1986) 3.29
Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol (1996) 2.03
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature (1993) 1.90
Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene (1998) 1.81
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75
Parosteal lipomas: a new perspective. Pathology (1992) 1.75
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol (1987) 1.74
Treatment of intraocular inflammatory disease with cyclosporin A. Lancet (1983) 1.74
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol (2001) 1.70
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
P element-mediated in vivo deletion analysis of white-apricot: deletions between direct repeats are strongly favored. Genetics (1994) 1.66
Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol (1997) 1.58
Psammomatoid (juvenile) ossifying fibroma of the orbit. Ophthalmology (1985) 1.57
Identification of the aminoglycoside binding site in rat renal brush border membranes. J Pharmacol Exp Ther (1982) 1.48
Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol (2001) 1.48
Occupational risk factors for sarcoma subtypes. Epidemiology (1999) 1.48
Pedunculated malignant melanoma. Dermatol Surg (2000) 1.46
Tuberous sclerosis associated with congenital lymphedema. Pediatr Dermatol (2000) 1.46
Treatment of tufted angioma with interferon alfa: role of bFGF. Pediatr Dermatol (1999) 1.44
IL-12 synthesis by human Langerhans cells. J Immunol (1996) 1.43
Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol (1997) 1.39
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis (1984) 1.37
Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol (1986) 1.34
Apoptosis: definition, mechanisms, and relevance to disease. Am J Med (1999) 1.31
Production of arteriosclerosis by homocysteinemia. Am J Pathol (1970) 1.31
Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene (1998) 1.29
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet (1981) 1.28
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol (1992) 1.23
Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol (1994) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells. Arch Dermatol (1993) 1.19
Juvenile active ossifying fibroma. Report of four cases. J Neurosurg (1997) 1.19
Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol (2000) 1.16
Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis (1985) 1.13
Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.11
Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am J Med (1984) 1.08
Psoriasis associated with human immunodeficiency virus in an infant. Pediatr Dermatol (1999) 1.07
Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol (1996) 1.05
Oxygen deprivation-induced injury to isolated rabbit kidney tubules. J Clin Invest (1985) 1.04
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med (1990) 1.04
GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am J Physiol Endocrinol Metab (2000) 1.04
Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol (1992) 1.03
Methotrexate induces differentiation of human keratinocytes. Proc Natl Acad Sci U S A (1992) 1.02
Radiologic and pathologic analysis of solitary bone lesions. Part II: periosteal reactions. Radiol Clin North Am (1981) 1.01
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol (1985) 1.01
Development of porous defects in plasma membranes of adenosine triphosphate-depleted Madin-Darby canine kidney cells and its inhibition by glycine. Lab Invest (1998) 1.00
Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.99
Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion (1986) 0.98
Increases of cell ATP produced by exogenous adenine nucleotides in isolated rabbit kidney tubules. Am J Physiol (1986) 0.98
Polyadenylylation in copia requires unusually distant upstream sequences. Proc Natl Acad Sci U S A (1991) 0.97
Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol (1996) 0.97
Alterations in renal cortex cation homeostasis during mercuric chloride and gentamicin nephrotoxicity. Exp Mol Pathol (1983) 0.97
Serine protease inhibitors suppress cytochrome c-mediatedcaspase-9 activation and apoptosis during hypoxia-reoxygenation. Biochem J (2000) 0.96
Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats. Kidney Int (1996) 0.96
Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity. J Clin Invest (1984) 0.95
Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: localization in T cells. Am J Clin Pathol (1984) 0.95
Hydrogen peroxide-induced cell and tissue injury: protective effects of Mn2+. Inflammation (1991) 0.94
Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens (1993) 0.94
Mitochondrial bioenergetics during the initiation of mercuric chloride-induced renal injury. I. Direct effects of in vitro mercuric chloride on renal mitochondrial function. J Biol Chem (1982) 0.94
Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol (1999) 0.93
Radiologic and pathologic analysis of solitary bone lesions. Part I: internal margins. Radiol Clin North Am (1981) 0.93
Mitochondrial bioenergetics during the initiation of mercuric chloride-induced renal injury. II. Functional alterations of renal cortical mitochondria isolated after mercuric chloride treatment. J Biol Chem (1982) 0.93
Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK1). Relationships to phospholipid degradation and unesterified fatty acid accumulation. J Clin Invest (1988) 0.92
The effect of gentamicin on calcium uptake by renal mitochondria. Life Sci (1982) 0.92
Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol (1998) 0.92
Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int (1996) 0.92
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med (1985) 0.91
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients. Proc Natl Acad Sci U S A (1995) 0.91
A case of lymphoproliferative disease presenting as juvenile rheumatoid arthritis. Diagnosis by synovial fluid examination. Am J Med (1973) 0.91
Human umbilical vein endothelial cell killing by activated neutrophils. Loss of sensitivity to injury is accompanied by decreased iron content during in vitro culture and is restored with exogenous iron. Lab Invest (1992) 0.90
Use of interleukin-2 in patients with acquired immunodeficiency syndrome. J Biol Response Mod (1984) 0.90
Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity. Am J Kidney Dis (1982) 0.90
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol (1999) 0.89
Alterations in renal cortical phospholipid content induced by gentamicin: time course, specificity, and subcellular localization. Am J Physiol (1983) 0.89
Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome. Ann N Y Acad Sci (1984) 0.88
Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol (1997) 0.88
Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J Leukoc Biol (1997) 0.88
Role of interferon in AIDS. Ann N Y Acad Sci (1984) 0.88
Vasopressin-induced increases of cytosolic calcium in LLC-PK1 cells. Am J Physiol (1986) 0.88
Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature. Acta Derm Venereol (1997) 0.87
Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients. Transplant Proc (1984) 0.87
Misleading CT in parosteal osteosarcoma. AJR Am J Roentgenol (1981) 0.86
Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results. Ann N Y Acad Sci (1984) 0.86
Radiologic and pathologic analysis of solitary bone lesions. Part III: matrix patterns. Radiol Clin North Am (1981) 0.86
Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection. Am J Pathol (2001) 0.85
Characterization of Ca2+ transport in rat renal brush-border membranes and its modulation by phosphatidic acid. Biochem J (1983) 0.84
Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. Bone Marrow Transplant (2002) 0.84
Occupational chlorophenol exposure and soft tissue sarcoma risk among men aged 30-60 years. Am J Epidemiol (1998) 0.84
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leuk Res (2005) 0.84
Cyclophosphamide pneumonitis. Thorax (1978) 0.84
Th2 cytokine profile in cutaneous T-cell lymphoma. J Invest Dermatol (1995) 0.84
Calcium dependence of integrity of the actin cytoskeleton of proximal tubule cell microvilli. Am J Physiol (1996) 0.84